• Something wrong with this record ?

Cheek-midface lifting with lateral canthoplasy for the repair of complex iatrogenic lower eyelid ectropion

A. Kopecký, AC. Rokohl, PA. Wawer Matos, J. Němčanský, LM. Heindl

. 2022 ; 32 (4) : 2085-2092. [pub] 20210820

Language English Country United States

Document type Journal Article

PURPOSE: To assess the efficiency and safety of cheek-midface lifting for the ophthalmoplastic reconstructive surgical repair of cicatricial lower eyelid malpositions after previously failed surgery. METHODS: In two ophthalmoplastic clinics, 14 eyelids of 13 patients underwent transconjunctival cheek-midface lifting. In a retrospective audit, changes in margin-reflex distance 2 (MRD2), snap-back test, the position of the eyelid after surgery including improving of the presurgical scleral show, the overall patient's satisfaction as well as complications after surgery were recorded. RESULTS: Following transconjunctival cheek-midface lifting, there was a significant improvement of MRD2, snap-back test, and the scleral show (p < 0.001, respectively). However, in three patients the scleral show persisted despite improved MRD2. All patients were satisfied with the results of the surgery. No post-surgical long-term complications were developed. CONCLUSION: Cheek-midface lifting can be a useful technique in severe cicatricial lower eyelid ectropion after previously failed surgery and is a safe and effective reconstructive method for ophthalmic surgeons with good cosmetical results and little postoperative long-term complications.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025312
003      
CZ-PrNML
005      
20221031101113.0
007      
ta
008      
221017s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/11206721211039334 $2 doi
035    __
$a (PubMed)34414803
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kopecký, Adam $u Ophthalmology Clinic, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Faculty of Medicine, University Ostrava, Ostrava, Czech Republic $1 https://orcid.org/https://orcid.org/0000000217820617
245    10
$a Cheek-midface lifting with lateral canthoplasy for the repair of complex iatrogenic lower eyelid ectropion / $c A. Kopecký, AC. Rokohl, PA. Wawer Matos, J. Němčanský, LM. Heindl
520    9_
$a PURPOSE: To assess the efficiency and safety of cheek-midface lifting for the ophthalmoplastic reconstructive surgical repair of cicatricial lower eyelid malpositions after previously failed surgery. METHODS: In two ophthalmoplastic clinics, 14 eyelids of 13 patients underwent transconjunctival cheek-midface lifting. In a retrospective audit, changes in margin-reflex distance 2 (MRD2), snap-back test, the position of the eyelid after surgery including improving of the presurgical scleral show, the overall patient's satisfaction as well as complications after surgery were recorded. RESULTS: Following transconjunctival cheek-midface lifting, there was a significant improvement of MRD2, snap-back test, and the scleral show (p < 0.001, respectively). However, in three patients the scleral show persisted despite improved MRD2. All patients were satisfied with the results of the surgery. No post-surgical long-term complications were developed. CONCLUSION: Cheek-midface lifting can be a useful technique in severe cicatricial lower eyelid ectropion after previously failed surgery and is a safe and effective reconstructive method for ophthalmic surgeons with good cosmetical results and little postoperative long-term complications.
650    _2
$a tvář $x chirurgie $7 D002610
650    12
$a ektropion $x etiologie $x chirurgie $7 D004483
650    _2
$a oční víčka $x chirurgie $7 D005143
650    _2
$a lidé $7 D006801
650    _2
$a iatrogenní nemoci $7 D007049
650    _2
$a pooperační komplikace $7 D011183
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rokohl, Alexander C $u Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Center for Integrated Oncology (CIO) Aachen-Bonn-Cologne-Duesseldorf, Cologne, Germany
700    1_
$a Wawer Matos, Philomena A $u Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $1 https://orcid.org/https://orcid.org/0000000184434858
700    1_
$a Němčanský, Jan $u Ophthalmology Clinic, University Hospital Ostrava, Ostrava, Czech Republic $u Faculty of Medicine, University Ostrava, Ostrava, Czech Republic $1 https://orcid.org/https://orcid.org/0000000319796419
700    1_
$a Heindl, Ludwig M $u Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany $u Center for Integrated Oncology (CIO) Aachen-Bonn-Cologne-Duesseldorf, Cologne, Germany
773    0_
$w MED00180219 $t European journal of ophthalmology $x 1724-6016 $g Roč. 32, č. 4 (2022), s. 2085-2092
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34414803 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031101110 $b ABA008
999    __
$a ok $b bmc $g 1854828 $s 1176602
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 32 $c 4 $d 2085-2092 $e 20210820 $i 1724-6016 $m European journal of ophthalmology $n Eur J Ophthalmol $x MED00180219
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...